You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Sign In
This page location is:
Lab Test Reference Manual
Human Reference Manual
Pages
25374
Lab Test Reference Manual
Human Reference Manual
Currently selected
25374
Buprenorphine, Urine, Confirm Only by LCMS
Marshfield Lab Public WebSite
Marshfield Clinic Public WebSite
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Search
Test Code
Laboratory Section
All
Test Category
All
Browse By Test Name
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Additional Information
Libraries
Newsletter Document Library
Regional Menus Pages
Lists
Lab Clinical Practice Guidelines
Antimicrobial Susceptibility Panels
Toxicology Information
Urine Preservatives
Requisition Instructions
Testing
Newsletter Links
Newsletters 2014
Newsletters 2015
Newsletters 2016
Newsletters 2017
Newsletters 2018
Cumulative Antibiogram Reports
testz
Human Test Code IDs
Recent
Newsletters 2020
Site Contents
Buprenorphine, Urine, Confirm Only by LCMS
Test Code: CO-BUP
Overview
Ordering
Specimen
Performing
Clinical/Interpretive
Contacts
Coding
Synonyms/Keywords
Synonyms, Keywords
Buprenex, Suboxone, Subutex, Temgesic
Useful For
Useful For
Detecting exposure to buprenorphine to monitor compliance in taking prescribed medications or to detect abuse
Specimen Requirements
Specimen Requirements
Fasting Required
Specimen Type
Preferred Container/Tube
Acceptable Container/Tube
Specimen Volume
Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
No
Urine
Sage urine collection container
Sterile plastic container with no preservatives
7 mL
5 mL
3 mL
Specimen Stability Information
Specimen Stability Information
Specimen Type
Temperature
Time
Urine
Refrigerate (Preferred)
14 days
Ambient
14 days
Frozen
14 days
Performing Laboratory Information
Performing Laboratory Information
Performing Location
Day(s) Test Performed
Analytical Time
Methodology/Instrumentation
Marshfield
Monday through Friday
2-4 days
Beckman AU680 Clinical Chemistry System with Emit Immunoassay and Liquid Chromatography/Time of Flight (LC-MS-QToF) or Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) using Multiple Reaction Monitoring (if needed for confirmation)
Test Information
Test Information
This test was developed and its performance characteristics determined by Marshfield Labs. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity testing.
This test is a LCMS confirmation only for Buprenorphone. It is intended for use only in patients where an initial drug screening test has already been performed at the time of the specimen collection (i.e. Point-of-Care drug screening cup, dipstick, etc...). The specimen will not be screened by immunoassay in the laboratory; it will only be tested by LCMS. If an initial drug screen has not been performed at the specimen collection site, it is more appropriate to order the "Buprenorphine, Urine" (BUP) test code which includes an initial screen.
This test will detect the presence of buprenorphine and its metabolite norbuprenorphine.
Buprenorphine is a member of the opioid family and is used as an alternative to methadone in the treatment of heroin addiction and as an analgesic for treatment of moderate to severe pain. Buprenorphine is metabolized to norbuprenorphine. Measurement of buprenorphine and norbuprenorphine assist the clinician in determining patient compliance with treatment.
Reference Range Information
Reference Range Information
Performing Location
Reference Range
Marshfield
Negative. Positives are reported with a quantitative LC-MS-QToF or LC-MS/MS result.
Interpretation
Interpretations
Current Cutoff Levels for Toxicology
Outreach CPTs
Outreach CPT Codes
CPT
Modifier
(if needed)
Quantity
Description
Comments
80348
1
Buprenorphine Confirmation by LCMS
G0480
1
Buprenorphine Confirmation by LCMS
For Medicare/Medicaid
Classification
Classification
This test was developed and its performance characteristics determined by Marshfield Labs. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity testing.
Synonyms/Keywords
Synonyms, Keywords
Buprenex, Suboxone, Subutex, Temgesic
Ordering Applications
Ordering Applications
Ordering Application
Description
COM
Buprenorphine Confirm, Urine
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Specimen Requirements
Fasting Required
Specimen Type
Preferred Container/Tube
Acceptable Container/Tube
Specimen Volume
Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
No
Urine
Sage urine collection container
Sterile plastic container with no preservatives
7 mL
5 mL
3 mL
Specimen Stability Information
Specimen Stability Information
Specimen Type
Temperature
Time
Urine
Refrigerate (Preferred)
14 days
Ambient
14 days
Frozen
14 days
Useful For
Useful For
Detecting exposure to buprenorphine to monitor compliance in taking prescribed medications or to detect abuse
Reference Range Information
Reference Range Information
Performing Location
Reference Range
Marshfield
Negative. Positives are reported with a quantitative LC-MS-QToF or LC-MS/MS result.
Interpretation
Interpretations
Current Cutoff Levels for Toxicology
For more information visit:
http://labtestsonline.org
Performing Laboratory Information
Performing Laboratory Information
Performing Location
Day(s) Test Performed
Analytical Time
Methodology/Instrumentation
Marshfield
Monday through Friday
2-4 days
Beckman AU680 Clinical Chemistry System with Emit Immunoassay and Liquid Chromatography/Time of Flight (LC-MS-QToF) or Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) using Multiple Reaction Monitoring (if needed for confirmation)
For billing questions, see Contacts
Outreach CPTs
Outreach CPT Codes
CPT
Modifier
(if needed)
Quantity
Description
Comments
80348
1
Buprenorphine Confirmation by LCMS
G0480
1
Buprenorphine Confirmation by LCMS
For Medicare/Medicaid
Classification
Classification
This test was developed and its performance characteristics determined by Marshfield Labs. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity testing.
Return To Top
For most current information refer to the Marshfield Laboratory online reference manual.